Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.

Summary

In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.

Eligibility

Inclusion Criteria:

* Age: ≥18 years old.
* Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy.
* Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions.
* Have a mobile phone to be able to contact the person and download the physical activity level app.
* Eastern Cooperative Oncology Group performance status (ECOG) ≤2.
* Life expectancy \>12 months.
* Availability and desire to participate throughout the study period.

Exclusion Criteria:

* Have a contraindication to moderate-high intensity exercise.
* Other significant medical disorders: including psychiatric illnesses chronic or recurrent; intellectual disability, musculoskeletal problems, cardiac or pulmonary disorders that interfere with physical exercise; other malignant tumors in the last five years, with the exception of therapeutically controlled skin cancer; any other illness that may be seen affected or aggravated by physical exercise.
* Have plans to be outside city more than two weeks.
* People who are already physically active (that comply with the recommendations of WHO: \> 150 minutes of exercise moderate/weekly, plus training force two days/week).
* Treatment based only with immunotherapy.
* Central nervous system involvement due to lymphoma.
* Have any important history that limit the capacity of the patient to participate in the study.

Conditions2

Browse More Trials